Filing Flows › Comparisons › TELA vs LNSR
Tela Bio vs Lensar: TELA and LNSR compared
Tela Bio is the larger company: $19.3M of revenue in its latest quarter (Q2 2026) against $16.5M for Lensar (Q2 2026). Lensar is growing faster (+18% against -4% a year earlier). Lensar is more profitable, with an operating margin of 12.9% against -48.1%.
Where the money goes: TELA and LNSR
Tela Bio (TELA) · Q2 2026
Tela Bio, Q2 2026: revenue $19.3M (-4% year over year), operating margin -48.1%, net loss $11.3M, operating cash flow −$9.4M. The chart follows the revenue to costs, profit and cash.
Lensar (LNSR) · Q2 2026
Lensar, Q2 2026: revenue $16.5M (+18% year over year), operating margin 12.9%, net earnings $3.5M, operating cash flow −$127K. The chart follows the revenue to costs, profit and cash.
| Tela Bio (TELA) | Lensar (LNSR) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $19.3M | $16.5M |
| Revenue growth, Y/Y | -4% | +18% |
| Operating margin | -48.1% | 12.9% |
| Net earnings | −$11.3M | $3.5M |
| Net margin | -58.4% | 21.4% |
| Operating cash flow | −$9.4M | −$127K |
Where the revenue comes from
Lensar
- Product: $13.0M (79%)
- Other revenues: $1.8M (11%)
- Service: $1.7M (10%)
Questions
Which is bigger, Tela Bio or Lensar?
Tela Bio is the larger company: $19.3M of revenue in its latest quarter (Q2 2026) against $16.5M for Lensar (Q2 2026).
Is Tela Bio or Lensar growing faster?
Lensar is growing faster (+18% against -4% a year earlier).
Which is more profitable, Tela Bio or Lensar?
Lensar is more profitable, with an operating margin of 12.9% against -48.1%.
More: Tela Bio earnings · how Tela Bio makes money · Lensar earnings · how Lensar makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.